Tesamorelin
What it is
Tesamorelin is a synthetic 44-amino-acid analogue of growth-hormone-releasing hormone with an N-terminal trans-3-hexenoic acid group that protects it from enzymatic breakdown. It has been studied in clinical trials and is supplied here as a research reagent.
Where it has been studied
- GHRH receptor pharmacology
- Visceral adipose tissue models
- IGF-1 axis studies
Selected literature
- Efficacy and safety of tesamorelin in people with HIV on integrase inhibitorsRusso SC et al. · AIDS, 2024 · PMID 38905488
- Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLDFourman LT et al. · JCI Insight, 2020 · PMID 32701508
- Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trialsBadran AS et al. · Obes Res Clin Pract, 2026 · PMID 41545261
PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.
